IRCT20160706028815N5
Not yet recruiting
Phase 2
The effect of addition of selenium to treatment regimen of hospitalized patients with COVID-19 on the outcome of disease compared with control group
Sabzevar University of Medical Sciences0 sites40 target enrollmentTBD
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Sabzevar University of Medical Sciences
- Enrollment
- 40
- Status
- Not yet recruiting
- Last Updated
- 5 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •COVID\-19 patient
- •Presence of COVID\-19 infection in the lung imaging
- •COVID\-19 PCR positive patients
- •Age more than 18 years old
Exclusion Criteria
- •Mechanical ventilation
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Phase 3
effect of selenium in systemic lupus erythematosusIRCT20210717051914N2Ahvaz University of Medical Sciences56
Recruiting
Phase 2
Evaluation of the effect of selenium on patients with thyroid cancer treated with radioactive iodineThyroid cancer.Neoplasm of uncertain behavior of thyroid glandD44.0IRCT20201129049534N6Esfahan University of Medical Sciences60
Completed
Phase 2
Investigation of the effect of Selenium in beta thalassemia majorthalassemia major.Beta thalassemiaD56.1IRCT20180603039959N3Ahvaz University of Medical Sciences42
Recruiting
Not Applicable
Selenium and Coronary Artery Disease: Should we supplement high risk patients?Coronary Artery DiseaseCardiovascular - Other cardiovascular diseasesACTRN12605000412639Dr Nathalie van Havre400
Recruiting
Phase 3
Effect of selenium on covid-19 diseaseIRCT20190418043307N1Deputy Dean of Research and Technology, Ilam university of medical science100